A 12-week study comparing moclobemide and sertraline in the treatment of outpatients with atypical depression

Journal of Psychopharmacology

Volumn 13, Issue 4, 1999, Pages 406-414

  Søgaard, Jesper ^a   Lane, Roger M ^b   Latimer, Paul ^c   Behnke, Kirsten ^d   Christiansen, Poule E ^e   Nielsen, Bjarne ^a   Ravindran, Arun V ^f   Reesal, Robin T ^g   Goodwin, Daryl P ^a  

^a Pfizer Inc ^*  (United Kingdom)

^b PFIZER INC   (United States)

^c KELOWNA GENERAL HOSPITAL   (Canada)

^d Alberta Professional Building ^*  (Denmark)

^e Sandgate Road Surgery ^*  (Denmark)

^f ROYAL OTTAWA HOSPITAL   (Canada)

^g Alberta Professional Building   (Canada)

Author keywords

Atypical depression; Moclobemide; Sertraline

Indexed keywords

MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTPATIENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SLEEP;

EID: 0033370115     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988119901300412     Document Type: Article

References (21)

1. Blehar M C, Lewy A J (1990) Seasonal mood disorder. Psychopharm Bull 26: 465-494
2. Fabre L F, Abuzzahab F S, Amin S, Claghorn J L, Mendels J, Petrie W M, Dube S, Small J G (1995) Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo. Biol Psychiatry 38: 592-602
3. Fitton A, Faulds D, Goa K L (1992) Moclobemide a review of its pharmacological properties and therapeutic use in depressive illness. Drugs 43: 561-596
4. Greist J, Chouinard G, DuBoff E, Halaris A, Kim S W, Koran L, Liehowitz M, Lydiard B, Rasmussen S, White K, Sikes C (1995) Double-blind parallel comparison of three dosages of sertraline in outpatients with obsessive compulsive disorder. Arch Gen Psychiatry 52: 289-295
5. Guy W, ed. (1976) ECDEU assessment manual for psychopharmacology, rev. edn. National Institute of Mental Health; US Dept of Health, Education and Welfare Publication (ADM) 91 338, Rockville, MD
6. Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32: 50-55
7. Larsen J K et al. (1991) Moclohemide in depression: a randomized multicentre trial against isocarboxazide and clomipramine emphasizing atypical depression. Acta Psychiatrica Scand 84: 564-570
8. Liebowitz M R, Quitkin F M, Stewart J W, McGrath P J, Harrison W M, Markowitz J S, Rahkin J G, Tricarno E, Goetz D M, Klein D F (1988) Antidepressant specificity in atypical depression. Arch Gen Psychiatry 45: 129-137
9. Londborg P D, Wolkow R, Smith W T, DuBoff E, England D, Ferguson J, Rosenthal M, Weise C (1998) Sertraline in the treatment of panic disorder: a multisite, double-blind, placebo-controlled fixed dose investigation. Br J Psychiatry 173: 54-60
10. Lonnqvist J, Sihvo S, Syvalahti E, Kiviruusu O (1994) Moclobemide and fluoxetine in atypical depression: a double-blind trial. J Affect Disord 32: 169-177
11. Murdoch D, McTavish D (1992) Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive compulsive disorder. Drugs 44: 604-624
12. Pande A C, Birkett M, Fechner-Bates S, Haskett R F, Greden J F (1996) Fluoxetine versus phenelzine in atypical depression Biol Psychiatry 40: 1017-1020
13. Parrott A C, Hindmarch I (1978) Factor analysis of a sleep evaluation questionnaire. Psychol Med 8: 325-329
14. Quitkin F M, Stewart J W, McGrath PJ et al. (1993) Columbia atypical depression: a subgroup of depressives with better response to tricyclic antidepressants or placebo. Br J Psychiatry 163: 30-34
15. Revicki D A, Turner R R, Martindale J J (1992) Reliability and validity of a health-related quality of life battery for evaluating outpatient antidepressant treatment. Qual Life Res 1: 257-266
16. Stewart J W, McGrath P J, Rabkin J G, Quitkin F M (1993a) Atypical depression: a valid clinical entity? Psychiatr Clin North Am 16: 479-495
17. Stewart J W, Rabkin J G, Quitkin F M et al. (1993b) Atypical Depression. In Dunner D L (ed.), Current psychiatric therapy. WB Saunders Company, Philadelphia, pp. 215-220
18. Thase M E, Mallinger A G, McKnight D, Himmelhoch J M (1992) Treatment of imipramine resistant recurrent depression: IV. A double-blind, cross-over study of tranylcypromine in anergic bipolar depression. Am J Psychiatry 149: 195-198
19. Tiller J et al. (1989) A sequential double-blind study of moclobemide and diazepara in patients with atypical depression. J Affect Disord 16: 181-187
20. Williams J B W, Link M J, Rosenthal N E, Terman M (1988) Structured interview guide for the Hamilton Depression Rating Scale, Seasonal Affective Disorders Version (SIGH-SAD). New York State Psychiatric Institute, New York
21. Yonkers K A, Halbreich U, Freeman E, Brown C, Endicott J, Frank E, Parry B, Pearlstein T, Severino S, Stout A, Stone A, Harrison W, for the Sertraline Premenstrual Dysphoric Collaborative Study Group (1997) Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. JAMA 278: 983-988